Loading clinical trials...
Loading clinical trials...
A Phase III Study Comparing Etoposide and Cisplatin (EP) With Irinotecan and Cisplatin (IP) Following EP Plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for Limited-Stage Small-Cell Lung Cancer : JCOG0202-MF
Conditions
Interventions
Etoposide and cisplatin after chemoradiotherapy
Irinotecan and cisplatin after chemoradiotherapy
Locations
37
Japan
Aichi Cancer Center Hospital
Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi-ken, Japan
Aichi Cancer Center,Aichi Hospital
Okazaki,Kake-machi,Kuriyado,18, Aichi-ken, Japan
National Cancer Center Hospital East
Kashiwa-shi,Kashiwanoha,6-5-1, Chiba, Japan
National Hospital Organization Shikoku Cancer Center
Matsuyama,Horinouchi,13, Ehime, Japan
Kyushu University Hospital
Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan
Gifu Municipal Hospital
Gifu,Kashima-cho,7-1, Gifu, Japan
Start Date
September 1, 2002
Primary Completion Date
September 1, 2011
Completion Date
September 1, 2011
Last Updated
September 22, 2016
Lead Sponsor
Haruhiko Fukuda
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions